Magis, Delphine http://orcid.org/0000-0002-4392-9413
D’Ostilio, Kevin
Lisicki, Marco
Lee, Chany
Schoenen, Jean
Funding for this research was provided by:
Fondation Roi Baudouin (Fonds Malou Malou)
Article History
Received: 24 April 2018
Accepted: 6 August 2018
First Online: 20 August 2018
Ethics approval and consent to participate
: All patients gave written informed consent. The study was conducted in accordance with the Declaration of Helsinki and was approved by the Belgian Federal Agency for Medicines and Health Products (FAMHP, ref. n°80 M0618) and by the local Ethics Committee (CHR Citadelle, Liège, Belgium, ref. 1426). The study was registered in clinicaltrials.gov (identification n° NCT02462395).
: Not applicable.
: Delphine Magis has received travel and research grants from electroCore LLC.Kevin D’Ostilio has nothing to disclose.Marco Lisicki has nothing to disclose.Chany Lee has nothing to disclose.Jean Schoenen is a consultant for Cefaly Technology, Chordate and Neuramodix.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.